European Leukemia Trial Registry
Trial: ENESTPath

More Details
Title Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML
Scientific Title A Prospective, Randomized, Open Label, Two Arm Phase III Study to Evaluate Treatment Free Remission (TFR) Rate in Patients With Philadelphia-positive CML After Two Different Durations of Consolidation Treatment With Nilotinib 300mg BID
Short Title ENESTPath
Trialgroup NN
Type of Trial multicentric, randomized, prospective, open-label, double-group
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.04.2013
Leader Saußele, Prof. Dr. med., Susanne
Shortprotocol Shortprotocol
created 05.08.2013 Johannes Kraus
changed 14.11.2016 Eva-Maria Ableidinger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |